Physician Assistant · Grand Rapids, MI
NPI
1568910602
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3271 Clear Vista Ct NE
Grand Rapids, MI, 49525
Phone (616) 267-7293
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
287 services
Medicare patients, 2024
175
Average age 68
Drug cost, 2024
$6.5M
4,418 prescriptions
Company payments, 2025
$2,239
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey D Ryan-Stout was code 99214 (office e&m - established), 228 times for 154 patients. In total Jeffrey D Ryan-Stout billed 287 services in 9 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 228 | 154 | $56.20 | $13K |
| 20610 Joint Injection | Office | 36 | 18 | $23.90 | $860 |
| 99204 Office E&M - New | Office | 15 | 15 | $82.20 | $1,233 |
By year: 2022 $30K for 2,349 services; 2023 $32K for 3,599 services; 2024 $15K for 287 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey D Ryan-Stout prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 884 prescriptions and refills. In total Jeffrey D Ryan-Stout wrote 4,418 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 884 | 2,302 | 296 | $59K |
| Prednisone Generic | 662 | 1,148 | 245 | $4,873 |
| Methotrexate Methotrexate Sodium | 523 | 1,190 | 181 | $19K |
| Enbrel Sureclick Etanercept | 339 | 364 | 53 | $2.6M |
| Leflunomide Generic | 152 | 335 | 56 | $11K |
| Folic Acid Generic | 148 | 407 | 53 | $1,037 |
| Sulfasalazine Dr Sulfasalazine | 130 | 302 | 51 | $8,812 |
| Humira Pen Adalimumab | 114 | 115 | 11 | $933K |
| Tramadol Hcl Generic | 94 | 96 | 18 | $681 |
| Orencia Clickject Abatacept | 89 | 96 | 15 | $539K |
| Allopurinol Generic | 78 | 211 | 26 | $1,276 |
| Meloxicam Generic | 65 | 160 | 24 | $461 |
| Sulfasalazine Generic | 65 | 152 | 22 | $2,736 |
| Humira(Cf) Pen Adalimumab | 58 | 61 | Under 11 | $393K |
| Diclofenac Sodium Generic | 55 | 76 | 24 | $945 |
Brand drugs: 1,140 claims; generic drugs: 3,228 claims; opioid claims: 178.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey D Ryan-Stout $2,239 ($2,239 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $744.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 36 | $744 |
| Amgen Inc. AMGN | 54 | $678 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $215 |
| UCB, Inc. UCB.BR | 6 | $147 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $145 |
| Janssen Biotech, Inc. JNJ | 2 | $93.86 |
| Organon LLC OGN | 4 | $47.95 |
| Pfizer Inc. PFE | 2 | $43.69 |
| Fresenius Kabi USA, LLC | 1 | $30.78 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $25.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.